Role of melatonin in blood pressure regulation: An adjunct anti‐hypertensive agent

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2018-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1440-1681.12942PMID 29603319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin supplementation plus exercise behavior ameliorate insulin resistance, hypertension and fatigue in a rat model of type 2 diabetes mellitus.

  2017cited by this paper
• Effects of melatonin on mechanisms involved in hypertension using human umbilical vein endothelial cells

  2017cited by this paper
• Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension

  2017cited by this paper
• The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension

  2017cited by this paper
• Sleep: important considerations for the prevention of cardiovascular disease

  2016cited by this paper
• How Does Melatonin Impact Diurnal Variations of Blood Pressure in Arterial Hypertension Due to The Autonomic Neuropathy

  2015cited by this paper
• Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin

  2014cited by this paper
• Peripheral and Central Effects of Melatonin on Blood Pressure Regulation

  2014cited by this paper
• One night on-call: sleep deprivation affects cardiac autonomic control and inflammation in physicians.

  2013cited by this paper
• A fractal approach to dynamic inference and distribution analysis

  2013cited by this paper
• Nocturnal urinary melatonin excretion is associated with non-dipper pattern in elderly hypertensives

  2013cited by this paper
• Heart rate variability in normal and pathological sleep

  2013cited by this paper
• The role of melatonin in hypertension: a brief review

  2012cited by this paper
• Sleep duration versus sleep insufficiency as predictors of cardiometabolic health outcomes.

  2012cited by this paper
• Melatonin membrane receptors in peripheral tissues: distribution and functions.

  2012cited by this paper
• Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome

  2011cited by this paper
• INFLUENCE OF CIRCADIAN TIME OF HYPERTENSION TREATMENT ON CARDIOVASCULAR RISK: RESULTS OF THE MAPEC STUDY

  2010cited by this paper
• Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States.

  2010cited by this paper
• Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies.

  2010cited by this paper
• Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

  2010cited by this paper
• Melatonin interactions with blood pressure and vascular function during l‐NAME‐induced hypertension

  2010cited by this paper
• Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability

  2010cited by this paper
• Renal Impairment of Pure Autonomic Failure

  2009cited by this paper
• Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats

  2009cited by this paper
• Can nocturnal hypertension predict cardiovascular risk?

  2009cited by this paper
• Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.

  2008cited by this paper
• Deficiency of Lung Antioxidants in Idiopathic Pulmonary Arterial Hypertension

  2008cited by this paper
• EFFECTS OF MELATONIN ON BLOOD PRESSURE IN STRESS‐INDUCED HYPERTENSION IN RATS

  2008cited by this paper
• The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome.

  2008cited by this paper
• The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension.

  2007cited by this paper
• Melatonin as a potential antihypertensive treatment

  2007cited by this paper
• Melatonin receptors in humans: biological role and clinical relevance.

  2006cited by this paper
• Acute effects of oral melatonin administration on arterial distensibility, as determined by carotid-femoral pulse wave velocity, in healthy young men.

  2006cited by this paper
• Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1. Blood Pressure Measurement in Humans. A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research

  2006cited by this paper
• Neuropharmacologic Distinction of Neurogenic Orthostatic Hypotension Syndromes

  2006cited by this paper
• Melatonin reduces night blood pressure in patients with nocturnal hypertension.

  2006cited by this paper
• Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile.

  2005cited by this paper
• Prolonged melatonin administration decreases nocturnal blood pressure in women.

  2005cited by this paper
• Functional MT1 and MT2 melatonin receptors in mammals

  2005cited by this paper
• Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

  2005cited by this paper
• Continuous Light Exposure and Sympathectomy Suppress Circadian Rhythm of Blood Pressure in Rats

  2004cited by this paper
• Treatment by n-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve.

  2004cited by this paper
• Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension

  2004cited by this paper
• Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.

  2004cited by this paper
• Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure

  2004cited by this paper
• Melatonin modulates the light‐induced sympathoexcitation and vagal suppression with participation of the suprachiasmatic nucleus in mice

  2003cited by this paper
• Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure

  2003cited by this paper
• Melatonin: detoxification of oxygen and nitrogen-based toxic reactants.

  2003cited by this paper
• Impaired nocturnal melatonin secretion in non-dipper hypertensive patients.

  2003cited by this paper
• Decreased nocturnal synthesis of melatonin in patients with coronary artery disease.

  2003cited by this paper
• Chronic antioxidant treatment improves sympathetic functions and β-adrenergic pathway in the spontaneously hypertensive rats

  2003cited by this paper
• No influence of melatonin on cerebral blood flow in humans.

  2003cited by this paper
• The melatonin receptor subtype MT2 is present in the human cardiovascular system

  2003cited by this paper
• Melatonin receptors and their regulation: biochemical and structural mechanisms.

  2003cited by this paper
• Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats.

  2003cited by this paper
• Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans

  2003cited by this paper
• MT(2) melatonin receptors are present and functional in rat caudal artery.

  2002cited by this paper
• Dual coupling of MT(1) and MT(2) melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure.

  2002cited by this paper
• 2[125I]Iodomelatonin binding and interaction with β‐adrenergic signaling in chick heart/coronary artery physiology

  2002cited by this paper
• The effects of melatonin on Ca2+ homeostasis in endothelial cells

  2002cited by this paper
• Caudate hemorrhage as a possible complication of midodrine-induced supine hypertension.

  2001cited by this paper
• Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators.

  2001cited by this paper
• 24h VARIATION IN THE EXPRESSION OF THE mt1 MELATONIN RECEPTOR SUBTYPE IN CORONARY ARTERIES DERIVED FROM PATIENTS WITH CORONARY HEART DISEASE

  2001cited by this paper
• Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men.

  2001cited by this paper
• Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy

  2001cited by this paper
• Relationship between short-term and long-term blood pressure variabilities in essential hypertensives

  2001cited by this paper
• EXPRESSION OF THE MT1 MELATONIN RECEPTOR SUBTYPE IN HUMAN CORONARY ARTERIES

  2001cited by this paper
• Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats

  2001cited by this paper
• Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives

  2001cited by this paper
• Autonomic activity during human sleep as a function of time and sleep stage

  2001cited by this paper
• Low urinary 6‐sulphatoxymelatonin levels in patients with coronary artery disease

  2000cited by this paper
• Sympathetically mediated hypertension in autonomic failure.

  2000cited by this paper
• Hypertensive cardiovascular damage in patients with primary autonomic failure.

  2000cited by this paper
• Decreased melatonin synthesis in patients with coronary artery disease.

  1999cited by this paper
• Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway.

  1999cited by this paper
• Clinical features and evaluation of the primary chronic autonomic failure syndromes

  1999cited by this paper
• Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men.

  1999cited by this paper
• Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension.

  1999cited by this paper
• Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins.

  1999cited by this paper
• Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

  1999cited by this paper
• Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences?

  1999cited by this paper
• Melatonin mediates two distinct responses in vascular smooth muscle.

  1998cited by this paper
• Influences of melatonin administration on the circulation of women.

  1998cited by this paper
• Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats.

  1998cited by this paper
• Diurnal rhythms in norepinephrine and acetylcholine synthesis of sympathetic ganglia, heart and adrenals of aging rats: effect of melatonin.

  1998cited by this paper
• Melatonin improves cerebral circulation security margin in rats.

  1998cited by this paper
• Influences of melatonin administration on the circulation of women.

  1998cited by this paper
• Potentially beneficial cardiovascular effects of melatonin administration in women

  1997cited by this paper
• Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study.

  1997cited by this paper
• A relationship between heat loss and sleepiness: effects of postural change and melatonin administration.

  1997cited by this paper
• Shy Drager syndrome.

  1997cited by this paper
• Arterial disease in dipper and nondipper hypertensive patients.

  1997cited by this paper
• Blood Pressure Rhythms in Sleep Disorders and Dysautonomia

  1996cited by this paper
• Melatonin receptors: are there multiple subtypes?

  1995cited by this paper
• Neural control of the pineal gland.

  1995cited by this paper
• Impaired nocturnal secretion of melatonin in coronary heart disease.

  1995cited by this paper
• Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis.

  1994cited by this paper
• Diurnal variations of blood pressure and microalbuminuria in essential hypertension.

  1994cited by this paper
• Sympathetic-nerve activity during sleep in normal subjects.

  1993cited by this paper
• Autoradiographic localization of putative melatonin receptors in the brains of two Old World primates: Cercopithecus aethiops and Papio ursinus.

  1993cited by this paper

• Agomelatine and the potential inverse risk of metabolic disorders: a nationwide cohort study with an active comparator design in Taiwan.

  2026cites this paper
• Comparison of the Effects of Melatonin and Midazolam on Hemodynamic Status in Patients Candidate for Cataract Surgery: A Randomized Controlled Clinical Trial

  2025cites this paper
• A novel model describing blood pressure profiles

  2025cites this paper
• Morning light exposure: a potential modifier of cardiovascular risk factor

  2025cites this paper
• The impact of melatonin and its agonist on blood pressure and serum endothelin-1 in continuous light and pinealectomized rats

  2025cites this paper
• The roles of melatonin and potassium channels in relaxation response to ang 1–7 in diabetic rat isolated aorta

  2025cites this paper
• Metabolic disorders after traumatic brain injury: a narrative review of systemic consequences

  2025influential citation
• Comprehensive Effects of Melatonin Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose–Response Meta-Analysis

  2025cites this paper
• Melatonin ameliorates ox-LDL-induced lipid accumulation and enhances ABCA1 expression in VSMCs via inhibition of the TRPV1-Ca2+-calpain signaling pathway.

  2025cites this paper
• Dietary index for gut microbiota and hypertension risk: a cross-sectional NHANES study

  2025cites this paper
• Mild and Severe Hypertension Differentially Induce Internal Circadian Misalignment, Sleep-Wake Fragmentation, and Neurocardiac Desynchronization in Rats.

  2025cites this paper
• Maumere exercise therapy and low salt diet in hypertension sufferers: an effort to lower blood pressure

  2024cites this paper
• PHARMACOLOGICAL EFFECTS OF MELATONIN AND ITS POTENTIAL APPLICATION IN THERAPY OF GOUT AND ASSOCIATED DISEASES

  2024cites this paper
• Assessing the Premedication Properties of Sublingual Melatonin in Young Women Undergoing Cesarean Section With Spinal Anesthesia: A Double-Blind Randomized Study

  2024cites this paper
• The roles of angiotensin-converting enzyme 2 inhibitor, melatonin and its agonist on angiotensin II reactivity in intact and denuded rat aortic rings

  2024cites this paper
• Systematic review of melatonin in cerebral ischemia-reperfusion injury: critical role and therapeutic opportunities

  2024cites this paper
• A Clinical, Pharmacological, and Formulation Evaluation of Melatonin in the Treatment of Ocular Disorders—A Systematic Review

  2024cites this paper
• ELICITATION WITHIN EHTA: POTENTIAL EFFICACY OF MELATONIN MEDICATION FOR STEMI PATIENTS WITH DETECTED HIGH RISK OF REPERFUSION VENTRICULAR FIBRILLATION DURING PCI

  2024cites this paper
• Antioxidant and Anti-Inflammatory Properties of Melatonin in Secondary Traumatic Brain Injury

  2024cites this paper
• Investigating the Role of Dietary Melatonin Supplementation in Ameliorating Pulmonary Hypertension Syndrome in Cold-stressed Broiler Chickens

  2024cites this paper
• Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matter

  2024cites this paper
• Alamandin and especially melatonin attenuate pulmonary arterial hypertension induced by monocrotalin

  2024cites this paper
• The vascular influence of melatonin on endothelial response to angiotensin II in diabetic rat aorta

  2024cites this paper
• Overlapping action of melatonin and female reproductive hormones-Understand the impact in pregnancy and menopause.

  2024cites this paper
• Exposure to light at night (LAN) and risk of overweight/obesity, hypertension, and diabetes: a systematic review and meta-analysis

  2024cites this paper
• Melatonin and blood pressure: a narrative review

  2024cites this paper
• EFFECTS OF MELATONIN ON BLOOD PRESSURE IN THE ELDERLY

  2024cites this paper
• Circadian Rhythms Disrupted by Light at Night and Mistimed Food Intake Alter Hormonal Rhythms and Metabolism

  2023cites this paper
• The Melatonin Derivative ITH13001 Prevents Hypertension and Cardiovascular Alterations in Angiotensin II-Infused Mice

  2023cites this paper
• Revealing Melatonin’s Mysteries: Receptors, Signaling Pathways, and Therapeutics Applications

  2023cites this paper
• Timing Matters: The Interplay between Early Mealtime, Circadian Rhythms, Gene Expression, Circadian Hormones, and Metabolism—A Narrative Review

  2023cites this paper
• Potential Neuroprotective Role of Melatonin in Sepsis-Associated Encephalopathy Due to Its Scavenging and Anti-Oxidative Properties

  2023cites this paper
• Melatonin Supplementation Reduces Nighttime Blood Pressure But Does Not Affect Blood Pressure Reactivity in Normotensive Adults on a High Sodium Diet.

  2023cites this paper
• Melatonin ameliorates atherosclerosis by suppressing S100a9-mediated vascular inflammation.

  2023cites this paper
• miR-145 Alleviates Smooth Muscle Cell Phenotype Transition via ADAM17-Mediated ACE2 Shedding

  2023cites this paper
• Effect of Endogenous Melatonin Hormone on Cardiovascular System: A Review of Literature

  2023cites this paper
• Control of Arterial Hypertension by the AhR Blocker CH-223191: A Chronopharmacological Study in Chronic Intermittent Hypoxia Conditions.

  2023cites this paper
• Bioinformatic analysis of the coding region of the melatonin receptor 1b gene as a reliable DNA marker to resolve interspecific mammal phylogenetic relationships.

  2023cites this paper
• Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence, and Perspectives.

  2022cites this paper
• Estrogen-dependent depressor response of melatonin via baroreflex afferent function and intensification of PKC-mediated Nav1.9 activation

  2022cites this paper
• Melatonin as a Chronobiotic with Sleep-promoting Properties

  2022cites this paper
• Effects of melatonin administration on testicular hemodynamics, echotexture, steroids production, and semen parameters during the non-breeding season in Ossimi rams.

  2022cites this paper
• Role of the Antioxidant Activity of Melatonin in Myocardial Ischemia-Reperfusion Injury

  2022cites this paper
• Controlled‐release oral melatonin supplementation for hypertension and nocturnal hypertension: A systematic review and meta‐analysis

  2022cites this paper
• Melatonin: Translation of Ongoing Studies Into Possible Therapeutic Applications Outside Sleep Disorders.

  2022cites this paper
• Exploring the Role of Melatonin in Meditation on Cardiovascular Health

  2022cites this paper
• Physical activity alleviates negative effects of bedroom light pollution on blood pressure and hypertension in Chinese young adults.

  2022cites this paper
• Melatonin inhibits angiotensin II-induced atrial fibrillation through preventing degradation of Ang II Type I Receptor-Associated Protein (ATRAP).

  2022cites this paper
• Evidence for the Benefits of Melatonin in Cardiovascular Disease

  2022cites this paper
• Melatonin Attenuates Vascular Smooth Muscle Contraction Through the γ-Secretase/Notch Intracellular Domain/Myocardin Pathway

  2022cites this paper
• Protective Effects and Mechanisms of Melatonin on Stress Myocardial Injury in Rats

  2022cites this paper
• Effects of One Night of Forced Wakefulness on Morning Resting Blood Pressure in Humans: The Role of Biological Sex and Weight Status

  2022cites this paper
• The role of the circadian system in cardiovascular diseases and clinical implications

  2022cites this paper
• Essential Hypertension and Oxidative Stress: Novel Future Perspectives

  2022cites this paper
• Methods of Laboratory Evaluation of the Autonomic Nervous System in Wakefulness and Sleep

  2021cites this paper
• Особливості застосування мелатоніну в сучасних умовах — успішний досвід і нові можливості

  2021cites this paper
• Supraphysiological Role of Melatonin Over Vascular Dysfunction of Pregnancy, a New Therapeutic Agent?

  2021influential citation
• Melatonin Exerts Anti-Inflammatory, Antioxidant, and Neuromodulatory Effects That Could Potentially Be Useful in the Treatment of Vertigo

  2021cites this paper
• Caracterización del daño mecánico de la aorta en condición de hipoxia

  2021cites this paper
• Melatonin Prevents T Lymphocyte Infiltration to the Kidneys of Hypertensive Rats, Induced by a High-Salt Diet, by Preventing the Expression of CXCR3 Ligand Chemokines

  2021cites this paper
• The Circadian Rhythm of Thermoregulation Modulates both the Sleep/Wake Cycle and 24 h Pattern of Arterial Blood Pressure.

  2021cites this paper
• Role of melatonin in attenuation of hemodynamic response to intubation and anesthetic requirements: a randomized, controlled, double-blind study

  2021cites this paper
• Melatonin Prevents Chronic Kidney Disease-Induced Hypertension in Young Rat Treated with Adenine: Implications of Gut Microbiota-Derived Metabolites

  2021cites this paper
• Melatonin May Be Associated With Left Ventricular Diastolic Dysfunction in Pediatric Patients With Heart Failure

  2021cites this paper
• Photoperiod-induced alterations in biomarkers of oxidative stress and biochemical pathways in rats of different ages: Focus on individual physiological reactivity

  2021cites this paper
• Walnut consumption and cardiac phenotypes: The Coronary Artery Risk Development in Young Adults (CARDIA) study.

  2020cites this paper
• Insights into Potential Targets for Therapeutic Intervention in Epilepsy

  2020cites this paper
• Early Origins of Hypertension: Should Prevention Start Before Birth Using Natural Antioxidants?

  2020cites this paper
• Melatonin supplementation in the management of obesity and obesity-associated disorders: a review of physiological mechanisms and clinical applications.

  2020cites this paper
• On-shift naps are associated with systolic and diastolic blood pressure level among night working nursing professionals

  2020cites this paper
• Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties

  2020cites this paper
• Effects of melatonin on the passive mechanical response of arteries in chronic hypoxic newborn lambs.

  2020cites this paper
• Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease

  2020cites this paper
• The effects of melatonin on the oxidative stress and duration of atrial fibrillation after coronary artery bypass graft surgery: A Randomized Controlled Trial.

  2020cites this paper
• Melatonin Plays a Critical Protective Role in Nicotine-Related Abdominal Aortic Aneurysm

  2020cites this paper
• The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial.

  2020cites this paper
• Melatonin Relations with Energy Metabolism as Possibly Involved in Fatal Mountain Road Traffic Accidents

  2020cites this paper
• Getting an Early Start in Understanding Perinatal Asphyxia Impact on the Cardiovascular System

  2020cites this paper
• Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review

  2020cites this paper
• Thymosin β4: a multi-faceted tissue repair stimulating protein in heart injury.

  2020cites this paper
• Night, Darkness, Sleep, and Cardiovascular Activity

  2020cites this paper
• FRINGE AND CENTRAL EFFECTS OF MELATONIN ON BLOOD PRESSURE REGULATION

  2020cites this paper
• Acute metabolic effects of melatonin—A randomized crossover study in healthy young men

  2020cites this paper
• Efficiency of synthetic melatonin in comprehensive therapy of patients with a combination of irritable bowel syndrome with constipation, arterial hypertension and obesity

  2019cites this paper
• Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence.

  2019cites this paper
• Insights on melatonin as an active pharmacological molecule in cancer prevention: what's new?

  2019cites this paper
• Plasma levels of melatonin in dilated cardiomyopathy

  2019cites this paper
• The Role of Melatonin on Metabolic Factors related to Periodontal Disease in Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• Sleep disorders, nocturnal blood pressure, and cardiovascular risk: A translational perspective.

  2019cites this paper
• Old and New Roles and Evolving Complexities of Cardiovascular Clocks

  2019cites this paper
• Melatonin decreases M1 polarization via attenuating mitochondrial oxidative damage depending on UCP2 pathway in prorenin-treated microglia

  2019cites this paper
• Melatonin in Heart Failure: A Promising Therapeutic Strategy?

  2018cites this paper
• Pharmacological approaches to the correction of radiation- induced endothelial dysfunction

  2018cites this paper
• Melatonin as a Hormone: New Physiological and Clinical Insights.

  2018cites this paper
• An Overview of Melatonin as an Antioxidant Molecule: A Biochemical Approach

  2018cites this paper
• ENDOTHELIAL DYSFUNCTION UNDER INFLUENCE OF IONIZING RADIATION: PATHOGENETIC BASIS AND OPPORTUNITIES OF PHARMACOLOGICAL CORRECTION

  2018cites this paper
• UlogA ciRkADiJAlnog SiStemA U nAStAnkU kARDiovASkUlARnih BoleSti i kliniČke imPlikAciJe

  year unknowncites this paper
• modulates pulmonary hypertension

  year unknowncites this paper
• Summary PHARMACOLOGICAL EFFECTS OF MELATONIN AND ITS POTENTIAL APPLICATION IN THERAPY OF GOUT AND ASSOCIATED DISEASES

  year unknowncites this paper